Ketamine shows promise for quick depression relief in new study
NCT ID NCT06668571
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 33 times
Summary
This study looks at whether a single dose of intravenous ketamine can rapidly improve symptoms in adults with treatment-resistant depression. Researchers will measure changes in brain chemicals (GABA and glutamate) and depression scores. 30 participants will receive either ketamine or a placebo (salt water) infusion, and their progress will be tracked for 24 hours.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION (TRD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Conditions
Explore the condition pages connected to this study.